- Authentic and fully functional recombinant proteins/antigens manufactured in mammalian cells.
- Scalable stable expression technology with a very short timeframe: stable mini-pools are produced within 2-3 weeks after transfection for the most targets..
- Reagents for academic research, functional studies, components of diagnostic kits, recombinant antibodies, targets and candidates in drug discovery and development.
Daresbury Proteins Ltd specialises in mammalian recombinant protein production and cell line development which can be transferred into a third party’s cGMP setting.
As an emerging biotech, they developed our proprietary approach while delivering various proteins for cutting-edge research. Their experience and know-how allow them to obtain difficult-to-express proteins in a short period of time with uncompromising quality. Their stable expression vector system can increase protein expression by up to 50-fold when compared to alternative mammalian expression systems.